person

Asta L.

Country
Denmark
Department
Rheumatology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 2 partner sites.

Specializations

Cardiovascular Disease & Atherosclerosis

The investigator focuses on therapeutic strategies targeting atherosclerotic cardiovascular disease and related ischemic events.

  • Major adverse cardiovascular events (MACE)
  • LDL‑C reduction therapies
  • Coronary heart disease prevention
  • Myocardial infarction risk mitigation
  • Ischemic stroke reduction

Research emphasizes novel agents that modify lipid pathways and plaque stability.

Heart Failure Therapeutics

Work in this area addresses treatment of both reduced‑ejection and preserved‑ejection heart failure, including comorbid obesity.

  • Vericiguat efficacy in HFrEF
  • Metformin adjunct therapy
  • Fluid removal optimization
  • Novel oral agents for HFpEF/HFmrEF
  • Hospitalization and mortality outcomes

Efforts aim to lower cardiovascular death and improve quality of life for chronic heart failure patients.

Atrial Fibrillation & Stroke Prevention

Investigation centers on anticoagulation alternatives for individuals with atrial fibrillation at heightened stroke risk.

  • Asundexian versus apixaban
  • Stroke and systemic embolism endpoints
  • Bleeding risk assessment
  • ISTH major bleeding criteria
  • Benefit‑risk profiling

Studies seek to balance efficacy in preventing thromboembolic events with safety regarding hemorrhage.

Rheumatoid Arthritis & DMARD Management

Research advances therapeutic de‑escalation for elderly patients with well‑controlled rheumatoid arthritis.

  • cs‑/b‑/tsDMARD tapering strategies
  • Maintaining disease activity scores
  • Patient‑centered dose reduction
  • Long‑term safety of reduced therapy
  • Impact on functional outcomes

The goal is to minimize medication burden while preserving remission.

Infectious Disease Prevention & Critical Care

Efforts span vaccine immunogenicity and acute infection management, including sepsis and respiratory viruses.

  • RSV prophylaxis in infants
  • Meningococcal conjugate vaccine immunogenicity
  • Varicella vaccine comparative efficacy
  • Empirical antibiotic strategies in sepsis
  • Fluid overload treatment in ICU patients

Studies aim to enhance protective immunity and improve outcomes in critically ill populations.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.